Publications
-
Coregulation of multiple signaling mechanisms in pp60v-Src-induced closure of Cx43 gap junction channels.
Mitra SS,
Xu J, Nicholson BJ.
J Membr Biol.
2012;
245
(8):
495-506
-
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas.
Li G,
Mitra SS, Monje M, Henrich KN, Bangs CD, Nitta RT, Wong AJ.
J Neurooncol.
2012;
108
(3):
395-402
-
Heterogeneous reallocation of presynaptic efficacy in recurrent excitatory circuits adapting to inactivity.
Mitra A,
Mitra SS, Tsien RW.
Nat Neurosci.
2012;
15
(2):
250-7
-
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Willingham SB,
Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.
Proc Natl Acad Sci U S A.
2012;
109
(17):
6662-7
-
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma.
Monje M,
Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA.
Proc Natl Acad Sci U S A.
2011;
108
(11):
4453-8
-
The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis.
Nitta RT,
Del Vecchio CA, Chu AH, Mitra SS, Godwin AK, Wong AJ.
Oncogene.
2011;
30
(2):
234-44
-
Development of an EGFRvIII specific recombinant antibody.
Gupta P,
Han SY, Holgado-Madruga M, Mitra SS, Li G, Nitta RT, Wong AJ.
BMC Biotechnol.
2010:
10
72
-
Passive antibody-mediated immunotherapy for the treatment of malignant gliomas.
Mitra S,
Li G, Harsh GR.
Neurosurg Clin N Am.
2010;
21
(1):
67-76
-
Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression.
Li G,
Mitra S, Karamchandani J, Edwards MS, Wong AJ.
Neurosurgery.
2010;
66
(5):
963-8; discussion 968
-
The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.
Li G,
Mitra S, Wong AJ.
Neurosurg Clin N Am.
2010;
21
(1):
87-93
Help